{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:18Z","timestamp":1791576078344,"version":"4.3.4"},"reference-count":151,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.addr.2009.11.024","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T04:58:50Z","timestamp":1258174730000},"page":"560-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["Nanotechnology applied to the treatment of malaria"],"prefix":"10.1016","volume":"62","author":[{"given":"Nereide Stela","family":"Santos-Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Carla Furtado","family":"Mosqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2009.11.024_bib1","unstructured":"WHO, World Malaria Report (2008), http:\/\/www.who.int\/malaria\/wmr2008\/malaria2008.pdf, accessed on 15th April 2009."},{"key":"10.1016\/j.addr.2009.11.024_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-7-124","article-title":"Antimalarial drug use in general populations of tropical Africa","volume":"7","author":"Gardella","year":"2008","journal-title":"Malaria J."},{"key":"10.1016\/j.addr.2009.11.024_bib3","unstructured":"WHO, The Africa Malaria Report (2003), http:\/\/www.rollbackmalaria.org\/amd2003\/amr2003\/pdf\/amr2003.pdf, accessed on 15th June 2009."},{"key":"10.1016\/j.addr.2009.11.024_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1517\/13543784.14.7.871","article-title":"Antimalarial drugs: current status and new developments","volume":"14","author":"Rathore","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.addr.2009.11.024_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4269\/ajtmh.2009.80.326","article-title":"Review: provider practice and user behavior interventions to improve prompt and effective treatment of malaria: do we know what works?","volume":"80","author":"Smith","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.024_bib6","unstructured":"WHO, Global Malaria Control and Elimination (2008), http:\/\/apps.who.int\/malaria\/docs\/elimination\/MalariaControlEliminationMeeting.pdf, accessed on 30th June 2009."},{"key":"10.1016\/j.addr.2009.11.024_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-308X(05)61002-0","article-title":"Malaria chemotherapy","volume":"61","author":"Winstanley","year":"2006","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1590\/S0074-02762001000800002","article-title":"The search for new antimalarial drugs from plants used to treat fever and malaria or plants randomly selected: A review","volume":"96","author":"Krettli","year":"2001","journal-title":"Mem. I. Oswaldo Cruz"},{"key":"10.1016\/j.addr.2009.11.024_bib9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: Progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2009.11.024_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/138945009787581203","article-title":"Testing of natural products and synthetic molecules aiming at new antimalarials","volume":"10","author":"Krettli","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2009.11.024_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pt.2008.03.008","article-title":"HIV and malaria co-infection: interactions and consequences of chemotherapy","volume":"24","author":"Skinner-Adams","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(00)02727-6","article-title":"Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: A cohort study","volume":"356","author":"Whitworth","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2009.11.024_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJM199107113250206","article-title":"Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire \u2014 a prospective, longitudinal cohort study of 587 children","volume":"325","author":"Greenberg","year":"1991","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.addr.2009.11.024_bib14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/01.inf.0000101188.95433.60","article-title":"Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence","volume":"22","author":"Grimwade","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.addr.2009.11.024_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/600121","article-title":"A malaria vaccine for control: more progress","volume":"200","author":"Breman","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.024_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"S.V.E.G. RTS, randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.024_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2007.12.018","article-title":"Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS, S vaccine antigen","volume":"26","author":"Mettens","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2009.11.024_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-6-120","article-title":"World antimalarial resistance network (WARN) II: In vitro antimalarial drug susceptibility","volume":"6","author":"Bacon","year":"2007","journal-title":"Malaria J."},{"key":"10.1016\/j.addr.2009.11.024_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","article-title":"Therapeutic applications of colloidal drug carriers","volume":"3","author":"Barratt","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.addr.2009.11.024_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1166\/jbn.2007.038","article-title":"Nanomedicines: a new approach for the treatment of serious diseases","volume":"3","author":"Vauthier","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.addr.2009.11.024_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.addr.2008.02.013","article-title":"Clinical developments in drug delivery nanotechnology","volume":"60","author":"Forrest","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib22","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/JCM.01022-08","article-title":"Highly sensitive amperometric immunosensor for detection of Plasmodium falciparum histidine-rich protein 2 in serum of humans with malaria: comparison with a commercial kit","volume":"46","author":"Sharma","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2009.11.024_bib23","first-page":"83","article-title":"Alternative tools for field analysis on malarial infection: a reappraisal","volume":"160","author":"Wiwanitkit","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.addr.2009.11.024_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/13543784.12.2.197","article-title":"Delivery strategies for antiparasitics","volume":"12","author":"Kayser","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.addr.2009.11.024_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"Date","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0264-410X(02)00174-3","article-title":"Design and selection of vaccine adjuvants: animal models and human trials","volume":"20","author":"Alving","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2009.11.024_bib27","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"A phase I\/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS, S\/AS02A in malaria-naive adults","volume":"25","author":"Kester","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2009.11.024_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cimid.2007.07.015","article-title":"Particle-based vaccines for transcutaneous vaccination","volume":"31","author":"Combadi\u00e8re","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.024_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.trstmh.2005.01.008","article-title":"Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations","volume":"100","author":"Newton","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2009.11.024_bib31","first-page":"449","article-title":"Development of new derivatives of primaquine by association with lysosomotropic carriers","volume":"59","author":"Trouet","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.addr.2009.11.024_bib32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/AAC.48.4.1222-1228.2004","article-title":"Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice","volume":"48","author":"Mosqueira","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.024_bib33","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.lfs.2006.12.019","article-title":"Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices","volume":"80","author":"Leite","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-5173(03)00266-7","article-title":"Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66","volume":"260","author":"Carcaboso","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib35","doi-asserted-by":"crossref","first-page":"R409","DOI":"10.1016\/S0960-9822(01)00221-4","article-title":"Malaria: A sporozoite runs through it","volume":"11","author":"Krettli","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.addr.2009.11.024_bib36","unstructured":"WHO, Guidelines for the Treatment of Malaria (2006), http:\/\/www.whqlibdoc.who.int\/publications\/2006\/9241546948_eng.pdf, accessed on 20th March 2009."},{"key":"10.1016\/j.addr.2009.11.024_bib37","first-page":"245","article-title":"Adjuvant therapy in cerebral malaria","volume":"124","author":"Mohanty","year":"2006","journal-title":"Ind. J. Med. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1567202043480116","article-title":"Cerebral malaria \u2014 a neurovascular pathology with many riddles still to be solved","volume":"1","author":"Coltel","year":"2004","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib39","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/IAI.01852-06","article-title":"Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation","volume":"75","author":"Pouvelle","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2009.11.024_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00001432-199912000-00008","article-title":"New therapies and changing patterns of treatment for malaria","volume":"12","author":"Whitty","year":"1999","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.addr.2009.11.024_bib41","unstructured":"WHO, Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring (2005), www.who.int\/malaria\/rbm\/Attachment\/20041108\/SusceptibilityPlasmodium_report.pdf, accessed on 25th March 2009."},{"key":"10.1016\/j.addr.2009.11.024_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-6-119","article-title":"World antimalarial resistance network I: Clinical efficacy of antimalarial drugs","volume":"6","author":"Price","year":"2007","journal-title":"Malaria J."},{"key":"10.1016\/j.addr.2009.11.024_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pt.2004.09.004","article-title":"Of malaria, metabolism and membrane transport","volume":"20","author":"Becker","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","article-title":"Transporters involved in resistance to antimalarial drugs","volume":"27","author":"Valderramos","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pt.2008.09.005","article-title":"Recent highlights in antimalarial drug resistance and chemotherapy research","volume":"24","author":"Fidock","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib46","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.024_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543784.16.5.705","article-title":"Tafenoquine: a promising new antimalarial agent","volume":"16","author":"Crockett","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2009.11.024_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pt.2005.05.013","article-title":"Malaria parasite transporters as a drug-delivery strategy","volume":"21","author":"Biagini","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib49","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1242\/jcs.016758","article-title":"A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites","volume":"121","author":"Lehane","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib50","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib51","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/jpet.106.101154","article-title":"A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system","volume":"317","author":"Ho","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2009.11.024_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2008.05.010","article-title":"Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method","volume":"361","author":"Qiu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00008-4","article-title":"Severe falciparum malaria in children: Current understanding of pathophysiology and supportive treatment","volume":"79","author":"Newton","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2009.11.024_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneurol.2009.23","article-title":"Diagnosis and management of the neurological complications of falciparum malaria","volume":"5","author":"Mishra","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.addr.2009.11.024_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/353073a0","article-title":"Direct access to serum macromolecules by intraerythrocytic malaria parasites","volume":"353","author":"Pouvelle","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.024_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-6851(97)00039-X","article-title":"Characterization of macromolecular transport pathways in malaria-infected erythrocytes","volume":"87","author":"Goodyer","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0854.2007.00648.x","article-title":"Protein transport across the parasitophorous vacuole of Plasmodium falciparum: Into the great wide open","volume":"9","author":"Charpian","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.addr.2009.11.024_bib59","doi-asserted-by":"crossref","first-page":"15458","DOI":"10.1073\/pnas.0404037101","article-title":"Prodrugs of bisthiazolium salts are orally potent antimalarials","volume":"101","author":"Vial","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2009.11.024_bib60","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/AAC.00443-06","article-title":"Potent antihematozoan activity of novel bisthiazolium drug T16: Evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp","volume":"50","author":"Richier","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.024_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0020-7519(03)00133-4","article-title":"Apicoplast fatty acid biosynthesis as a target for medical intervention in Apicomplexan parasites","volume":"33","author":"Gornicki","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib62","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-03-1084","article-title":"Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs","volume":"104","author":"Biagini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.addr.2009.11.024_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s000180300002","article-title":"Colloidal drug carriers: Achievements and perspectives","volume":"60","author":"Barratt","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib64","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/jps.20875","article-title":"Role of nanotechnology in pharmaceutical product development","volume":"96","author":"Devalapally","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib65","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.addr.2007.11.008","article-title":"Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects","volume":"60","author":"Wong","year":"2008","journal-title":"Adv. Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens Iii","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib67","first-page":"196","article-title":"Long circulating nanocapsules: Interest in the treatment of severe malaria with halofantrine","volume":"61","author":"Legrand","year":"2003","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.addr.2009.11.024_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0731-7085(01)00611-2","article-title":"Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice","volume":"28","author":"Chimanuka","year":"2002","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.addr.2009.11.024_bib69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-006-9609-x","article-title":"Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence","volume":"23","author":"Longmuir","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.39.1.180","article-title":"Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice","volume":"39","author":"Owais","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2009.11.024_bib71","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.024_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2006.03.034","article-title":"Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles","volume":"319","author":"F\u00f6ger","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","article-title":"Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo","volume":"34","author":"Haas","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.addr.2009.11.024_bib74","first-page":"594","article-title":"Stealth liposomes","volume":"19","author":"Lasic","year":"1991","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2009.11.024_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"16","author":"Gref","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(01)00227-7","article-title":"Targeted drug conjugates: Principles and progress","volume":"53","author":"Garnett","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(96)00457-7","article-title":"Modulation of pharmacokinetic behavior of liposomes","volume":"24","author":"Scherphof","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-5173(95)04135-4","article-title":"Primaquine-loaded poly(lactide) nanoparticles: Physicochemical study and acute tolerance in mice","volume":"126","author":"Rodrigues","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib79","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/00034983.2001.11813665","article-title":"The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro","volume":"95","author":"Heurtault","year":"2001","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6","article-title":"Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics","volume":"39","author":"L\u00fcck","year":"1998","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib81","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib82","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/S0142-9612(01)00043-6","article-title":"Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules","volume":"22","author":"Mosqueira","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2009.11.024_bib83","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1023\/A:1012248721523","article-title":"Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effects of PEG chain length and density","volume":"18","author":"Mosqueira","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib84","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1166\/jnn.2006.444","article-title":"Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine","volume":"6","author":"Mosqueira","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2009.11.024_bib85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10717540802006211","article-title":"Liposomal polyethyleneglycol and polyethyleneglycol-peptide combinations for active targeting to liver in vivo","volume":"15","author":"Haynes","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2009.11.024_bib86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(86)80632-9","article-title":"Antibody-mediated targeting of liposomes to red cells in vivo","volume":"201","author":"Singhal","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2009.11.024_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-291X(87)91118-1","article-title":"Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles","volume":"148","author":"Agrawal","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2009.11.024_bib88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02703366","article-title":"Chloroquine delivery to erythrocytes in Plasmodium berghei-infected mice using antibody-bearing liposomes as drug vehicles","volume":"16","author":"Chandra","year":"1991","journal-title":"J. Biosci."},{"key":"10.1016\/j.addr.2009.11.024_bib89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2736(89)90037-0","article-title":"Therapeutic effect of chloroquine (CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: Comparison with combinations of antibodies and CQ or liposomal CQ","volume":"981","author":"Peeters","year":"1989","journal-title":"BBA \u2014 Biomembranes"},{"key":"10.1016\/j.addr.2009.11.024_bib90","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(99)00061-7","article-title":"Tuftsin-bearing liposomes in treatment of macrophage-based infections","volume":"41","author":"Agrawal","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib91","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/jps.21211","article-title":"Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver","volume":"97","author":"Robertson","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib92","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2009.11.024_bib93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-5793(71)80109-6","article-title":"Enzyme entrapment in liposomes","volume":"14","author":"Gregoriadis","year":"1971","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2009.11.024_bib94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bst0020117","article-title":"Drug entrapment in liposomes: possibilities for chemotherapy","volume":"2","author":"Gregoriadis","year":"1974","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2009.11.024_bib95","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-5173(85)90158-9","article-title":"Design of sterile muramyldipeptide-containing oligolamellar liposomes suitable for i.v. injection. Effect of liposome size and lipid composition on their ability to render peritoneal macrophages antitumoral","volume":"23","author":"Sponton","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-7799(98)01220-7","article-title":"Novel applications of liposomes","volume":"16","author":"Lasic","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.addr.2009.11.024_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(96)04710-2","article-title":"Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin","volume":"143","author":"Ramaldes","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib98","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/0024-3205(81)90176-4","article-title":"Oral ingestion of insulin liposomes: Effects of the administration route","volume":"28","author":"Weingarten","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib99","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0031-6989(88)80117-6","article-title":"Intracarotidal administration of liposomally-entrapped ATP: Improved efficiency against experimental brain ischemia","volume":"20","author":"Laham","year":"1988","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.addr.2009.11.024_bib100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.addr.2009.11.024_bib101","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-2478(90)90127-C","article-title":"Liposomes containing lipid A: A potent nontoxic adjuvant for a human malaria sporozoite vaccine","volume":"25","author":"Alving","year":"1990","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2009.11.024_bib102","first-page":"85","article-title":"Liposomes designed to avoid the reticuloendothelial system","volume":"343","author":"Papahadjopoulos","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2009.11.024_bib104","first-page":"347","article-title":"Liposomes in the chemotherapy of experimental murine malaria","volume":"73","author":"Pirson","year":"1979","journal-title":"Trans. R. Soc. S. Afr."},{"key":"10.1016\/j.addr.2009.11.024_bib105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00034983.1983.11811725","article-title":"Studies on the kinetics of uptake and distribution of free and liposome-entrapped primaquine, and of sporozoites by isolated perfused rat liver","volume":"77","author":"Smith","year":"1983","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-3084(90)90131-A","article-title":"The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey","volume":"53","author":"Madden","year":"1990","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.addr.2009.11.024_bib107","first-page":"187","article-title":"Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles","volume":"1331","author":"Cullis","year":"1997","journal-title":"BBA \u2014 Rev. Biomembranes"},{"key":"10.1016\/j.addr.2009.11.024_bib108","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/jm00398a026","article-title":"Arteether, a new antimalarial drug: Synthesis and antimalarial properties","volume":"31","author":"Brossi","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2009.11.024_bib109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(95)04273-3","article-title":"Evaluation of liposomal formulations containing the antimalarial agent, arteether","volume":"128","author":"Al-Angary","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00182-3","article-title":"In vivo evaluation of arteether liposomes","volume":"175","author":"Bayomi","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib111","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","article-title":"Physical and chemical evaluation of liposomes, containing artesunate","volume":"31","author":"Gabriels","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.addr.2009.11.024_bib112","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00034983.1980.11687359","article-title":"Primaquine liposomes in the chemotherapy of experimental murine malaria","volume":"74","author":"Pirson","year":"1980","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib113","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/0006-2952(82)90633-5","article-title":"The disposition of free and liposomally encapsulated antimalarial primaquine in mice","volume":"31","author":"Pirson","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.024_bib114","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1015927614920","article-title":"Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria","volume":"6","author":"Peeters","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/02652049509006778","article-title":"Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes","volume":"12","author":"Arica","year":"1995","journal-title":"J. Microencapsul"},{"key":"10.1016\/j.addr.2009.11.024_bib116","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/expr.1998.4282","article-title":"Plasmodium vinckei: Optimization of desferrioxamine B delivery in the treatment of murine malaria","volume":"89","author":"Postma","year":"1998","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib117","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(00)00338-0","article-title":"Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design","volume":"198","author":"Stensrud","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib118","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-5173(96)04801-6","article-title":"Interactions between liposomes and chitosan II: Effect of selected parameters on aggregation and leakage","volume":"146","author":"Henriksen","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 3","key":"10.1016\/j.addr.2009.11.024_bib119","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0264-410X(02)00174-3","article-title":"Design and selection of vaccine adjuvants: animal models and human trials","volume":"20","author":"Alving","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2009.11.024_bib120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/14760584.7.4.499","article-title":"Various carrier system(s) mediated genetic vaccination strategies against malaria","volume":"7","author":"Tyagi","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2009.11.024_bib121","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/iai.56.3.682-686.1988","article-title":"Liposomes, lipid A, and aluminium hydroxide enhance the immune response to a synthetic malaria sporozoite antigen","volume":"56","author":"Richards","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2009.11.024_bib122","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1128\/IAI.66.6.2859-2865.1998","article-title":"Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen","volume":"66","author":"Richards","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2009.11.024_bib123","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/iai.60.6.2438-2444.1992","article-title":"Adjuvant effects of liposomes containing lipid A: Enhancement of liposomal antigen presentation and recruitment of macrophages","volume":"60","author":"Verma","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2009.11.024_bib124","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2006.11.023","article-title":"Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB\/c mice","volume":"25","author":"Sharma","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2009.11.024_bib125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","article-title":"Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject","volume":"364","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib126","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2005.07.015","article-title":"Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy","volume":"303","author":"Dierling","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.06.021","article-title":"Development of SMEDDS using natural lipophile: Application to beta-Artemether delivery","volume":"362","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2008.06.012","article-title":"Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria","volume":"362","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.msec.2006.05.029","article-title":"Modification of nanostructured materials for biomedical applications","volume":"27","author":"Xu","year":"2007","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2009.11.024_bib132","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0168-3659(90)90087-A","article-title":"Nanoparticles \u2014 A colloidal drug delivery system for primaquine and metronidazole","volume":"12","author":"Labhasetwar","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2009.11.024_bib133","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1773-2247(05)50008-X","article-title":"PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether","volume":"15","author":"Bhadra","year":"2005","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.addr.2009.11.024_bib134","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11095-005-9396-9","article-title":"PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate","volume":"23","author":"Bhadra","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2005.01.026","article-title":"Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting","volume":"295","author":"Bhadra","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib136","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2009.11.024_bib137","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-5173(01)00796-7","article-title":"Improved oral bioavailability of artemisinin through inclusion complexation with beta- and gama-cyclodextrins","volume":"227","author":"Wong","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib138","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bcp.2006.10.030","article-title":"Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy","volume":"73","author":"Crandall","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.024_bib139","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/jps.20106","article-title":"Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with beta-cyclodextrin","volume":"93","author":"Hartell","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib140","first-page":"858","article-title":"Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems","volume":"62","author":"Onyeji","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.addr.2009.11.024_bib141","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12272-009-1130-4","article-title":"Dihydroartemisinin-cyclodextrin complexation: Solubility and stability","volume":"32","author":"Ansari","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.addr.2009.11.024_bib142","series-title":"Handbook of Pharmaceutical Controlled Release Technology","first-page":"359","article-title":"Large scale production of solid lipid nanoparticles (SLN\u2122) and nanosuspensions (DissoCubes\u2122)","author":"M\u00fcller","year":"2000"},{"key":"10.1016\/j.addr.2009.11.024_bib143","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","article-title":"Nanosuspensions: a promising drug delivery strategy","volume":"56","author":"Patravale","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2009.11.024_bib144","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/03639040701662388","article-title":"Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method","volume":"34","author":"Chingunpitak","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2009.11.024_bib146","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i2.10","article-title":"Nanocapsule technology: A review","volume":"19","author":"Couvreur","year":"2002","journal-title":"Crit. Rev. Ther. Drug"},{"key":"10.1016\/j.addr.2009.11.024_bib147","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2006.05.018","article-title":"Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity","volume":"64","author":"da Silva Santos","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2009.11.024_bib148","first-page":"411","article-title":"Polymeric nanocapsules as drug delivery systems: a review","volume":"9","author":"Legrand","year":"1999","journal-title":"S. T. P. Pharm. Sci."},{"key":"10.1016\/j.addr.2009.11.024_bib149","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.exppara.2005.12.017","article-title":"Plasmodium berghei: Development of an irreversible experimental malaria model in Wistar rats","volume":"113","author":"Pedroni","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.addr.2009.11.024_bib150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/02652040400015411","article-title":"Formulation and characterization of triclosan sub-micron emulsions and nanocapsules","volume":"21","author":"Maestrelli","year":"2004","journal-title":"J. Microencapsul"},{"key":"10.1016\/j.addr.2009.11.024_bib151","unstructured":"WHO, Global Health Observatory Map Gallery (2008), http:\/\/gamapserver.who.int\/mapLibrary\/Files\/Maps\/Global_Malaria_ITHRiskMap.JPG, acessed on 30th June 2009."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X09003652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:32:48Z","timestamp":1759206768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X09003652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":151,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0169409X09003652"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2009.11.024","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology applied to the treatment of malaria","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2009.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}